Targeting the Non-Canonical NF-?B Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma (2022)
Attributed to:
Therapeutic targeting of refractory/relapsed diffuse large B-cell lymphoma through systems biology
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers14061489
PubMed Identifier: 35326640
Publication URI: http://europepmc.org/abstract/MED/35326640
Type: Journal Article/Review
Parent Publication: Cancers
Issue: 6
ISSN: 2072-6694